Esperion Therapeutics, Inc. (ESPR)

2.89 0.05 (1.76%)

As of 2025-10-30 18:06:50 EST

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Traded asNasdaq: ESPR
ISINUS29664W1053
CIK0001434868
LEI549300OFU56UKEWVUS92
EIN—
SectorPharmaceutical
IndustryPharmaceutical Preparations
CEOSheldon Koenig
Employees—
Fiscal Year End1231
Address3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, 48108
Phone734-887-3903
Websitehttp://www.esperion.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
ESPREsperion Therapeutics, Inc.2025-10-30 18:06:502.890.051.76
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
ESPR0001434868Esperion Therapeutics, Inc.US29664W1053549300OFU56UKEWVUS92—Nasdaq2834Pharmaceutical Preparations1231DE3891 RANCHERO DRIVE, SUITE 150ANN ARBORMI48108UNITED STATESUS734-887-39033891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, 481083891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, 48108HDL THERAPEUTICS INCPharmaceutical2008Sheldon Koenig—http://www.esperion.com/435,100,000202,149,464201,622,825Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.2025-10-30 15:05:54
This is a preview of the latest data. Subscribe to access the full data.
ESPR Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
ESPR Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024435,100,000292,600,000205.3333197,848,88612,796,1816.9149
2023142,500,000-279,800,000-66.2562185,052,705108,479,875141.6689
2022422,300,000-170,200,000-28.725776,572,83013,751,22721.8893
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Joanne FoodyChief Medical Officer2024388,2880307,500195,200595,8601,870,559
Benjamin LookerGeneral Counsel2024471,0000205,000213,75011,6001,130,827
Sheldon L. KoenigChief Executive Officer, President2024745,8330930,700487,50029,0453,175,240
Benjamin HalladayChief Financial Officer2024467,3330348,500235,12511,5001,368,427
Eric WarrenChief Commercial Officer2024481,8670205,000218,25015,2501,149,844
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024304
2023240
2022199
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue332,314,000116,334,00075,475,000
Cost Of Revenue———
Gross Profit———
Research And Development Expenses46,238,00086,107,000118,927,000
General And Administrative Expenses163,073,000142,523,000109,082,000
Operating Expenses277,912,000271,897,000254,976,000
Operating Income54,402,000-155,563,000-179,501,000
Net Income-51,745,000-209,248,000-233,659,000
Earnings Per Share Basic-0.28-2.03-3.52
Earnings Per Share Diluted-0.28-2.03-3.52
Weighted Average Shares Outstanding Basic187,181,856103,106,61666,407,242
Weighted Average Shares Outstanding Diluted187,181,856103,106,61666,407,242
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents144,761,00082,248,000124,775,000
Marketable Securities Current—042,086,000
Accounts Receivable80,142,00048,494,00033,729,000
Inventories94,491,00065,623,00035,201,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current337,998,000201,065,000246,683,000
Marketable Securities Non Current———
Property Plant And Equipment254,0000164,000
Other Assets Non Current———
Total Assets Non Current5,823,0004,731,0001,256,000
Total Assets343,821,000205,796,000247,939,000
Accounts Payable51,650,00031,718,00023,040,000
Deferred Revenue8,518,00025,402,0003,507,000
Short Term Debt54,912,000——
Other Liabilities Current—990,000279,000
Total Liabilities Current246,233,000156,224,00092,308,000
Long Term Debt54,600,000261,600,000259,900,000
Other Liabilities Non Current———
Total Liabilities Non Current486,310,000504,566,000479,409,000
Total Liabilities732,543,000660,790,000571,717,000
Common Stock196,000118,00075,000
Retained Earnings-1,601,029,000-1,549,284,000-1,340,036,000
Accumulated Other Comprehensive Income00-2,000
Total Shareholders Equity-388,722,000-454,994,000-323,778,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization63,000164,000500,000
Share Based Compensation Expense11,993,00011,958,00015,215,000
Other Non Cash Income Expense———
Change In Accounts Receivable31,648,00014,765,00010,795,000
Change In Inventories28,868,00030,422,000807,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable12,432,0008,678,0005,603,000
Change In Other Liabilities———
Cash From Operating Activities-23,654,000-135,487,000-174,827,000
Purchases Of Marketable Securities0059,897,000
Sales Of Marketable Securities042,500,00068,001,000
Acquisition Of Property Plant And Equipment317,000——
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-317,00042,500,0008,104,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock513,0004,448,00090,849,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities29,000——
Cash From Financing Activities86,484,00050,460,00032,606,000
Change In Cash62,513,000-42,527,000-134,117,000
Cash At End Of Period144,761,00082,248,000124,775,000
Income Taxes Paid———
Interest Paid—58,976,00056,810,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-0.28-2.03-3.52
Price To Earnings Ratio-7.8571-1.4729-1.7699
Earnings Growth Rate-86.2069-42.3295-62.1912
Price Earnings To Growth Ratio0.09110.03480.0285
Book Value Per Share-2.0767-4.4128-4.8756
Price To Book Ratio-1.0594-0.6776-1.2778
Ebitda7,569,000-150,108,000-176,349,000
Enterprise Value376,551,083.2487,640,781.84548,842,117.66
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio-0.2817-0.575-0.8027
Capital Expenditures317,00000
Free Cash Flow-23,971,000-135,487,000-174,827,000
Return On Equity0.13310.45990.7217
One Year Beta1.5221.02660.8513
Three Year Beta0.99090.85320.9401
Five Year Beta0.98940.9611.0321
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Halladay BenjaminChief Financial Officer2025-09-177,046D474,862
Koenig Sheldon L.Director, President and CEO2025-09-1728,427D1,518,831
Looker BenjaminGeneral Counsel2025-09-176,267D393,670
Halladay BenjaminChief Financial Officer2025-07-1711D474,462
Looker BenjaminGeneral Counsel2025-07-171,304D399,937
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Parkside Financial Bank & Trust2025-09-301,0604002.65
Boomfish Wealth Group, LLC2025-09-30120,06145,3062.65
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC2025-09-3073,90023,9163.09
AMALGAMATED BANK2025-09-3017,0006,5382.6002
WOLVERINE ASSET MANAGEMENT LLC2025-09-30235,60088,9062.65
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
SEI INSTITUTIONAL INVESTMENTS TRUST2025-08-31SIIT Extended Market Index Fund - Class ASMXAX31,10069,0420.0057
PROSHARES TRUST2025-08-31ProShares Ultra Russell2000UWM20,21044,866.20.0123
PROSHARES TRUST2025-08-31ProShares Russell 2000 High Income ETFITWO4,2369,403.920.0151
PROSHARES TRUST2025-08-31ProShares Hedge Replication ETFHDG246546.120.0023
PROSHARES TRUST2025-08-31ProShares Russell 2000 Dynamic Buffer ETFRB279619.380.0151
This is a preview of the latest data. Subscribe to access the full data.